University of Alabama at Birmingham: Pancreatic Neoplasms trials
The registry lists 11 Pancreatic Neoplasms studies with University of Alabama at Birmingham as lead sponsor. 1 are open to participants now and 1 have results posted.
Early Phase 1 2Phase 2 4No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE StudyRecruitingNCT07671937Not applicable
- 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer PatientsTerminatedNCT00841035Phase 2Results posted
- Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine CancersWithdrawnNCT03623984Early Phase 1
- Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerTerminatedNCT03600623Early Phase 1
- Diet and Exercise After Pancreatic CancerCompletedNCT03187028Not applicable
- Characterizing the Pancreatic Cancer Proteome From Pancreatic JuiceCompletedNCT02277834
- Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic CancerCompletedNCT00968175Not applicable
- Pancreatic and Gastrointestinal Tumor Registry and Tissue CollectionCompletedNCT00584363
- CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00033384Phase 2
- ISIS 2503 in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00005594Phase 2
- Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the PancreasWithdrawnNCT00005591Phase 2